Liane M. McGlynn

The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism

Carlos Sebastián, Bernadette Zwaans, Dafne M. Silberman et al. · Cell · 2012 · 651 citations · Full text

Histone Modifications, Epigenetic Change, Histone Deacetylase Sirt6 +16

AKT activation predicts outcome in breast cancer patients treated with tamoxifen

Tove Kirkegaard, Caroline Witton, Liane M. McGlynn et al. · The Journal of Pathology · 2005 · 270 citations

Breast Oncology, Tamoxifen Treatment, Tamoxifen Resistance +14

Observer variation in immunohistochemical analysis of protein expression, time for a change?

Thomas Kirkegaard, Joanne Edwards, Sian Tovey et al. · Histopathology · 2006 · 235 citations

Socio-economic status is associated with epigenetic differences in the pSoBid cohort

Dagmara McGuinness, Liane M. McGlynn, P. Johnson et al. · International Journal of Epidemiology · 2012 · 200 citations · Full text

High Expression of Sphingosine 1-Phosphate Receptors, S1P1 and S1P3, Sphingosine Kinase 1, and Extracellular Signal-Regulated Kinase-1/2 Is Associated with Development of Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Patients

Carol Watson, Jaclyn S. Long, Clare Orange et al. · American Journal Of Pathology · 2010 · 169 citations · Full text

Breast Oncology, Tamoxifen Resistance, Sphingosine Kinase 1 +11